Generic Drugs Industry Analysis
Discover insightful information you need to be fully informed on the Generic Drugs Market. Reports include data on the Threats and Opportunities of Generic Drugs in today’s market place.
previous
| China Animal Medicines Mfg. Industry Profile - CIC2750 (ZFR00167) Through a comparative analysis on the development of animal medicines mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key... | May 2012 | £365 |
| China Chinese Prepared Medicines Mfg. Industry Profile - CIC2740 (ZFR00168) Through a comparative analysis on the development of Chinese prepared medicines mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides... | May 2012 | £365 |
| China Pharmaceutical & Medicine Mfg. Industry Profile - CIC2720 (ZFR00169) Through a comparative analysis on the development of pharmaceutical & medicine mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides... | May 2012 | £365 |
| Generic and innovative drugs market in Central Europe 2012 (PMR00071) Comparative analysis, reimbursement policies and development forecasts for 2012-2014The report is a comprehensive analysis of six Central European countries: Poland, Romania, Slovakia, the Czech Republic, Hungary and Bulgaria. It provides details of the characteristics of the generic and... | Apr 2012 | £2,065 |
| Global Human Growth Hormone Drugs Market (INF01671) 2011-2015TechNavio's analysts forecast the Global Human Growth Hormone Drug market to grow at a CAGR of 3 percent over the period 2011-2015. One of the key factors contributing to this... | Apr 2012 | £945 |
| Sumitomo Pharmaceutical Company Intelligence Report (ESP00699) Stryker Corporation, headquartered in Kalamazoo, Michigan, USA, develops, manufactures and markets orthopaedic products, including reconstructive products such as hip, knee and shoulder implants, trauma-related products such as fixation devices, spinal... | Apr 2012 | £195 |
| Cardiovascular Generic Drugs (ESP00455) Prospects and Opportunities to 2012Cardiovascular Generic Drugs: Prospects & Opportunities to 2012 Providing Detailed assessment and forecast for leading products by value to 2012 An assessment of patent expiry and challenges Competitive evaluation Analysis of significant litigation Patent expiry opportunities to... | Apr 2012 | £995 |
| The World Generic Market Report (ESP00631) 2012A complete global analysis of the prospects for markets and companies in this dynamic industry sector Features and benefits of this thoroughly-researched and highly-regarded management report: High quality: Original research, novel 5-year... | Apr 2012 | £795 |
| Ridaforolimus (7 country coverage) (GEW01430) Key patent, SPC, and data exclusivity expiryPipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for... | Mar 2012 | £310 |
| Gatifloxacin (7 country coverage) (GEW01434) Key patent, SPC, and data exclusivity expiryPipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for... | Mar 2012 | £310 |
| Cabazitaxel (7 country coverage) (GEW01433) Key patent, SPC, and data exclusivity expiryPipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for... | Mar 2012 | £310 |
| Palivizumab (7 country coverage) (GEW01350) Key patent, SPC, and data exclusivity expiryPipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for... | Mar 2012 | £310 |
| Tafluprost (7 country coverage) (GEW01432) Key patent, SPC, and data exclusivity expiryPipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for... | Mar 2012 | £310 |
| Apixaban (7 country coverage) (GEW01435) Key patent, SPC, and data exclusivity expiryPipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for... | Mar 2012 | £310 |
| Roflumilast (7 country coverage) (GEW01431) Key patent, SPC, and data exclusivity expiryPipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for... | Mar 2012 | £310 |
| Roflumilast - Comprehensive patent search (GEW01418) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams,... | Mar 2012 | £4,125 |
| Ridaforolimus - Comprehensive patent search (GEW01419) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams,... | Mar 2012 | £3,715 |
| Cabazitaxel - Comprehensive patent search (GEW01420) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams,... | Mar 2012 | £4,125 |
| Tafluprost - Comprehensive patent search (GEW01421) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams,... | Mar 2012 | £3,300 |
| Palivizumab - Comprehensive patent search (GEW01422) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams,... | Mar 2012 | £4,745 |
| Gatifloxacin - Comprehensive patent search (GEW01423) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams,... | Mar 2012 | £4,125 |
| Apixaban - Comprehensive patent search (GEW01424) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams,... | Mar 2012 | £3,300 |
| Ridaforolimus (44 country coverage) (GEW01425) Key patent, SPC, and data exclusivity expiryPipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for... | Mar 2012 | £700 |
| Gatifloxacin (44 country coverage) (GEW01436) Key patent, SPC, and data exclusivity expiryPipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for... | Mar 2012 | £700 |
| Cabazitaxel (44 country coverage) (GEW01427) Key patent, SPC, and data exclusivity expiryPipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for... | Mar 2012 | £700 |
